EUVIMEDEUVIMED entdecken
Open Access

Evaluating HEmopatch® in Reducing Seroma-Related Complications following Axillary Lymph Node DIssection: A Pilot Study (HEIDI)

Merel A Spiekerman van Weezelenburg, Lisa de Rooij, Loeki Aldenhoven, Pieter P H L Broos, Sander M J van Kuijk, Elisabeth R M van Haaren, Alfred Janssen, Yvonne L J Vissers, Geerard L Beets, James van Bastelaar

Breast Care · 2022 · 17 (6) · 567-572

DOI: 10.1159/000525839 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Care, online erschienen am 04.07.2022. Verfasst von Merel A Spiekerman van Weezelenburg und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Zuyderland Medical Centre, Sittard-Geleen, The Netherlands. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Axillary lymph node dissection (ALND) is performed to treat locoregional metastatic disease in breast cancer and melanoma patients. However, it is notorious for its complications, most commonly seroma formation and its sequelae. Ample research has been done to evaluate seroma formation after ALND; these results, however, have not been conclusive. Hence, this pilot study aimed to evaluate a readily available haemostatic patch, Hemopatch®, to assess its effect on seroma formation following ALND.

Methods

In this pilot study, a prospective cohort of 20 patients receiving Hemopatch® following ALND was compared to a retrospective cohort of patients who underwent ALND between 2014 and 2019. The primary outcome measure was the number of patients developing clinically significant seroma (CSS) after ALND. Additionally, the number of wound complications, subsequent interventions, additional outpatient clinic visits, and drain output was assessed. Differences between groups were deemed clinically relevant if the proportions differed >50% between groups.

Results

In total, 20 prospective and 42 retrospective patients were included. In the Hemopatch® group, 30% of the patients developed CSS, compared to 43% in the control group. Three patients in both groups developed a surgical site infection . Thirty-five percent of patients in the Hemopatch® group required additional unscheduled visits versus 62% of patients in the control group.

Conclusion

The application of Hemopatch® after ALND did not lead to a clinically relevant reduction of CSS and wound complications. However, fewer Hemopatch® patients required additional outpatient clinic visits. Due to the limited amount of participants, the true value of Hemopatch® in ALND remains unclear.

Schlagwörter

Stichwörter der Autor:innen

Breast cancerLymph node dissectionMelanomaSeroma

Autor:innen und Institutionen

  • Department of Surgery, Zuyderland Medical Centre, Sittard-Geleen, The Netherlands.
  • Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • GROW School for Oncology and Developmental Biology, University of Maastricht, Maastricht, The Netherlands.

Zitieren

APA

Spiekerman van Weezelenburg, M. A., de Rooij, L., Aldenhoven, L., Broos, P. P. H. L., van Kuijk, S. M. J., van Haaren, E. R. M., Janssen, A., Vissers, Y. L. J., Beets, G. L., & van Bastelaar, J. (2022). Evaluating HEmopatch® in Reducing Seroma-Related Complications following Axillary Lymph Node DIssection: A Pilot Study (HEIDI). Breast Care, 17(6), 567-572. https://doi.org/10.1159/000525839

Vancouver

Spiekerman van Weezelenburg MA, de Rooij L, Aldenhoven L, Broos PPHL, van Kuijk SMJ, van Haaren ERM, et al. Evaluating HEmopatch® in Reducing Seroma-Related Complications following Axillary Lymph Node DIssection: A Pilot Study (HEIDI). Breast Care. 2022;17(6):567-572. doi:10.1159/000525839

BibTeX
@article{SpiekermanvanWeezelenburg2022,
  author = {Spiekerman van Weezelenburg, Merel A and de Rooij, Lisa and Aldenhoven, Loeki and Broos, Pieter P H L and van Kuijk, Sander M J and van Haaren, Elisabeth R M and Janssen, Alfred and Vissers, Yvonne L J and Beets, Geerard L and van Bastelaar, James},
  title = {Evaluating HEmopatch® in Reducing Seroma-Related Complications following Axillary Lymph Node DIssection: A Pilot Study (HEIDI)},
  journal = {Breast Care},
  year = {2022},
  volume = {17},
  number = {6},
  pages = {567--572},
  doi = {10.1159/000525839}
}
Kostenlos starten →